Lv1
20 积分 2025-11-19 加入
Immune checkpoint inhibitors in melanoma
7个月前
已完结
The Challenge of Treating Anti-PD-1-Resistant Advanced Melanoma
7个月前
已完结
A review of the efficacy of prostate cancer therapies against castration-resistant prostate cancer
8个月前
已完结
Dynamic blood-based biomarkers predict early response to ipilimumab and nivolumab in advanced melanoma
8个月前
已完结
Survival of patients with advanced metastatic melanoma: The impact of novel therapies
9个月前
已完结
Cancer treatment and survivorship statistics, 2025
9个月前
已完结
Gaining momentum: New options and opportunities for the treatment of advanced melanoma
9个月前
已完结
Revolutionizing treatment of advanced melanoma with immunotherapy
9个月前
已完结
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
9个月前
已完结
Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date
9个月前
已完结
皖公网安备34019202002308
